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AKTIVITI ANTIMALARIA, TOKSISITI DAN SARINGAN FITOKIMIA 




Penurunan keberkesanan ubat antimalaria akibat penularan Plasmodium 
falciparum yang rintang ubat memerlukan usaha mencari ubat antimalaria dengan 
sasaran yang baharu. Quercus infectoria telah digunakan secara tradisional sebagai 
ubat herba bagi rawatan pospartum dan penyakit disebabkan parasit. Walau 
bagaimanapun, tiada sebarang aktiviti antimalaria yang pernah dilaporkan bagi 
tumbuhan ini. Oleh itu, kajian ini bertujuan menilai aktiviti antimalaria ekstrak mentah 
biji Q. infectoria secara in vitro. Kajian ini turut direka bagi menilai profil toksisiti dan 
menyaring sebatian fitokimia dalam tumbuhan ini. Potensi antimalaria ekstrak aseton, 
metanol, etanol dan akueus terhadap strain P. falciparum yang sensitif klorokuina 
(3D7) ditentukan melalui asai malaria berasaskan pendarfluor hijau SYBR I (MSF). 
Hanya ekstrak aseton dan metanol menunjukkan aktiviti antimalaria yang baik dengan 
kepekatan perencatan 50% (IC50) masing-masing iaitu 5.86 (1.64) dan 10.31 (1.90) 
μg/mL. Ujian sitotoksisiti ekstrak dinilai menggunakan sel selanjar fibroblas tikus 
(NIH/3T3), sel selanjar epitelial ginjal monyet (Vero) dan sel primer endotelial vena 
umbilikal manusia (HUVEC) melalui asai 3-(4, 5-dimetiltiazol-2-il)-2, 5-
difeniltetrazolium bromida (MTT). Ekstrak aseton dan metanol memaparkan 
kepekatan sitotoksisiti 50% (CC50) dalam julat antara toksik secara sederhana dan 
tidak toksik terhadap semua sel normal yang diuji. Penilaian sitotoksisiti menggunakan 
ujian kemautan udang brin (BSLT) turut menunjukkan semua ekstrak tidak toksik ke 
atas udang air garam berdasarkan indeks toksisiti Meyer. Selain asai hemolisis, asai 
xxii 
antioksidan menggunakan 2,2-difenil-1-pikrilhidrazil (DPPH) juga dilakukan 
terhadap ekstrak-ekstrak bagi melihat hubungkaitnya dengan hemolisis eritrosit 
manusia (kumpulan darah A+, B+, AB+ dan O+). Tiada kesan hemolitik berlaku 
terhadap eritrosit yang dirawat dengan semua ekstrak. Semua ekstrak turut 
mempamerkan aktiviti pemerangkapan radikal DPPH yang baik. Kandungan logam 
surih (plumbum, zink, kromium, tembaga dan kadmium) dalam ekstrak menunjukkan 
kepekatan di bawah tahap yang dibenarkan mengikut garis panduan WHO yang telah 
dianalisa dengan spektroskopi penyerapan atom (AAS). Pemeriksaan kandungan 
fitokimia menunjukkan kehadiran tanin dan flavonoid serta jumlah kandungan fenolik 
(TPC) dan jumlah kandungan flavonoid (TFC) yang tinggi dalam semua ekstrak.  
Kesan ekstrak aseton yang telah menunjukkan aktiviti antimalaria yang paling baik 
dengan nilai indeks selektiviti (SI) yang memuaskan terhadap pH vakuol pencernaan 
P. falciparum telah disiasat menggunakan penunjuk pendafluor bersifat ratiometrik, 
fluoresein isotiosianat (FITC)-dektran yang dimuatkan ke dalam parasit malaria 
peringkat trofozoit dan dianalisa dengan sitometri aliran. pH vakuol pencernaan yang 
dirawat dengan ekstrak aseton berubah secara signifikan mengikut kepekatan apabila 
dibandingkan dengan parasit yang tidak dirawat (p < 0.001). Secara keseluruhan, 
kajian ini memberikan pemahaman asas yang berharga mengenai keupayaan biji Q. 
infectoria sebagai calon antimalaria yang selamat dan diyakini. 
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The reduced efficacy of the mainstay antimalarial drugs due to widespread 
of drug-resistant Plasmodium falciparum has necessitated efforts to discover new 
antimalarial drugs with new targets. Quercus infectoria galls have been used 
traditionally as a herbal remedy for post-partum medication and treatment of parasitic 
diseases. However, the antimalarial activity of the galls has not been reported. Thus, 
this study was aimed at evaluating the in vitro antimalarial activity of Q. infectoria gall 
crude extracts. This study was also designed to evaluate the toxicity profiles and screen 
the phytochemical constituents. The antimalarial potential of acetone, methanol, 
ethanol and aqueous extracts against the chloroquine-sensitive strain (3D7) of P. 
falciparum was assessed via malarial SYBR Green-I fluorescence-based (MSF) assay. 
Only acetone and methanol extracts showed a promising antimalarial activity with 
50% inhibitory concentration (IC50) of 5.86 (1.64) and 10.31 (1.90) μg/mL, 
respectively. The cytotoxicity of the extracts was evaluated against mouse fibroblast 
cell (NIH/3T3), monkey kidney epithelial cell (Vero) and primary human umbilical 
vein endothelial cell (HUVEC) via 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. The acetone and methanol extracts showed 
50% cytotoxicity concentration (CC50) ranged from moderate toxic to non-toxic 
against all tested normal cells. The cytotoxicity evaluation using a brine shrimp 
lethality test (BSLT) showed that all extracts were non-toxic according to Meyer’s 
toxicity index. In addition to the haemolytic assay, a 2,2-diphenyl-1-picrylhydrazyl 
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(DPPH)-based antioxidant assay of the extracts was performed to observe its 
connection with haemolysis of human erythrocytes (A+, B+, AB+ and O+ blood groups). 
No haemolytic effect was observed on the erythrocytes treated with all extracts. All 
extracts exhibited excellent DPPH radical scavenging activities. The concentration of 
heavy metals (lead, zinc, chromium, copper and cadmium) analysed with atomic 
absorption spectroscopy (AAS) in all extracts was below the permissible level 
according to WHO guidelines. The phytochemical screening revealed the presence of 
tannins and flavonoids, and high amount of total phenolic content (TPC) and total 
flavonoid content (TFC) in all extracts. The effect of acetone extract which previously 
exhibited the most promising antimalarial activity and have satisfactory selectivity 
index (SI) values on the pH of the parasite’s digestive vacuole was examined using a 
ratiometric fluorescent probe, fluorescein isothiocyanate (FITC)-dextran incorporated 
into mid trophozoite stage-infected erythrocytes and analysed by flow cytometry. The 
pH of the digestive vacuole of acetone extract-treated parasites was significantly 
altered in a concentration-dependent manner compared to the untreated parasites (p < 
0.001). Overall, this study provides valuable insights of Q. infectoria gall capability as 








1.1 Background of the study 
 
Malaria overwhelms humans throughout the centuries. In 2018, the World 
Health Organization (WHO) reported 228 million cases of malaria with 405 000 deaths 
globally (WHO, 2019). The highest number of malaria cases and deaths was recorded 
in the African region, followed by the Southeast Asian, Eastern Mediterranean and 
Western Pacific regions. Although Malaysia was ranked among the ten malaria-
affected countries in the Western Pacific region that achieved zero indigenous cases 
of human malaria in 2018 (WHO, 2019), malaria-related deaths have still failed to 
reduce since 2010. Thus, malaria continues to pose a significant threat to the health 
system and economic development, requiring a massive effort for a malaria-free world. 
 
Five malaria parasites, namely Plasmodium vivax, Plasmodium ovale, 
Plasmodium malariae, Plasmodium knowlesi and Plasmodium falciparum are 
transmitted to humans by female Anopheles mosquitoes (Cowman et al., 2016). The 
last species accounts for the most malaria-associated deaths (WHO, 2019) and poses 
a great risk of severe clinical presentations after jeopardising the host erythrocytes 
(Talapko et al., 2019). During the intraerythrocytic stage, haemozoin and other toxic 
factors produced by the parasite stimulate macrophages and other cells to produce 
cytokines and other soluble factors that trigger fever and rigours and influence other 
severe pathophysiological functions (Cowman et al., 2016; Yusuf et al., 2017). 
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The elimination of Anopheles mosquito breeding sites with insecticides, 
the prevention of mosquito-human contacts with insecticide-treated bed nets and the 
use of malaria rapid diagnostic tests significantly reduce the number of malaria cases 
(Gachelin et al., 2018; Dhiman, 2019; Lechthaler et al., 2019). In the absence of 
effective vaccines, the treatment measure is strengthened by the use of antimalarial 
drug therapies (Achan et al., 2011; Guo, 2016; WHO, 2019). The decreased sensitivity 
of P. falciparum towards artemisinin-based combination therapies (ACTs) as the 
current front-line treatment has been reported in multiple locations of the Greater 
Mekong subregion (Noedl et al., 2010; Tun et al., 2016; He et al., 2019; Tse et al., 
2019). This is thought to be associated with mutations in the region of the pfKelch13 
gene (He et al., 2019). Therefore, finding new antimalarial agents, particularly with 
new mechanisms of action is urgently needed. 
 
Medicinal plants have been studied for many years as a source of new 
antimalarial agents (Katiyar et al., 2012; Rakotoarivelo et al., 2015). Several 
phytochemicals of the alkaloids, terpenes and phenolic compounds groups with 
numerous varieties such as phenolic acids, flavonoids and tannins exhibit antimalarial 
properties (Muñoz et al., 2000; Wink, 2012; Upadhyay et al., 2013). Artemisinin, a 
sesquiterpene lactone isolated from the leaves of  Artemisia annua is the example of 
the bioactive compound that has been commercially used as the antimalarial drug 
(Ashley & Phyo, 2018). Phenolic glycosides isolated from Flacourtia indica and 
polyphenolic flavonoid silymarin obtained from Silybum marianum have also been 
reported to possess antimalarial activity by inhibiting haem polymerisation activity to 
form haemozoin in the digestive vacuole of malaria parasite (Singh et al., 2017; Mina 
et al., 2020). Thus, the effect of phenolic-rich medicinal plants such as Quercus 
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infectoria against the malaria parasite can provide an insight into the discovery of new 
antimalarial drugs with novel mechanisms of action.  
 
Q. infectoria is a plant with a long history of traditional uses for various 
ailments including fever treatment (Everest & Ozturk, 2005; Jamal et al., 2011). The 
galls that also known as biji manjakani among Malaysians contain a high number of 
phenolics belonging to the compounds such as tannins, gallic acid, ellagic acid, 
pyrogallol, rutin and quercetin (Kheirandish et al., 2016; Abdullah et al., 2018; Tayel 
et al., 2018), which might contribute to the antiparasitic activities (Sawangjaroen et 
al., 2004; Sawangjaroen & Sawangjaroen, 2005; Ozbilgin et al., 2013; Kheirandish et 
al., 2016). In view of that, the present study was designed to determine the in vitro 
antimalarial activity and toxicity, to screen the phytochemical constituents of Q. 
infectoria gall crude extracts and to measure the pH of the digestive vacuole treated 
with the selected extract.  
 
1.2 The rationale of the study 
 
The crisis of antimalarial resistance not only complicates the management 
of malaria but also challenges the global elimination efforts to be achieved. Although 
the quest for new treatment regimens and development of the vaccine continues, none 
of them is readily available and licensed to be used to combat single drug- and 
multidrug-resistant malaria. Malaria is becoming harder to treat; therefore, the usage 




The discovery of potent antimalarial drugs coming from medicinal plants 
such as Q. infectoria galls is seen as a major approach to tackle the crisis of antimalarial 
resistance. Therefore, this is the first study that investigates the antimalarial activity of 
the medicinal plant, Q. infectoria galls. In an attempt to bridge the knowledge gap on 
the antimalarial study of the galls, toxicity and phytochemical screening have also been 
conducted as they play a significant role in determining the overall potential of the 
galls, providing an insightful view of the galls as a safer and selective antimalarial 
candidate. Additionally, as no investigations were conducted to explore the 
antimalarial effect of the galls, the effect of the galls on pH of the malaria parasite’s 
digestive vacuole has also investigated. The inhibitory activities of the haemoglobin 
degradation and haem detoxification by many phenolic compounds from several plants 
(Mamede et al., 2020; Tajuddeen & Van Heerden, 2019) could affect one of the 
physiological states of the digestive vacuole such as pH (Spiller et al., 2002; 
Wunderlich et al., 2012). The galls likely impaired proton pumps function that 
responsible for pH maintenance in the digestive vacuole, thereby altering the pH of the 
digestive vacuole. The outcomes could provide possible explanations on the 
antimalarial effect of the galls which can be used as the guideline for future 
investigation on the molecular mechanism underlying antimalarial action and further 
reflects the importance of the in-depth antimalarial investigation. 
 
The overall goal of these efforts is to provide a basic understanding of the 
antimalarial effect of the galls. As pH regulation of the malaria digestive vacuole is an 
important indicator of the physiological state of the parasite and critically crucial for 
haemoglobin digestion and subsequent haem detoxification in the host’s erythrocytes, 
this novel mechanism could be a possible approach in discovering new antimalarial 
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candidates. It could also further broaden the research on antimalarial drug discovery 
as well as add valuable insights to the existing knowledge on the mechanism of 
antimalarial action. Comprehensive understanding of the patterns and mechanisms of 
a potential plant on the malaria parasite will allow specific strategies to be tailored for 
the improvement of mode of antimalarial drugs action, as well as isolation and 
biosynthesis of valuable bioactive compounds. 
 
1.3 Objectives of the study 
 
1.3.1 General objective 
 
The study was aimed to determine the in vitro antimalarial activity and 
toxicity of different extracts of Q. infectoria galls. The study also was aimed to 
determine the pH changes of the digestive vacuole following treatment with the 
selected gall crude extract. 
 
1.3.2 Specific objectives 
 
1. To determine the antimalarial activity of different gall crude extracts; 
acetone, methanol, ethanol and aqueous against the chloroquine-sensitive 
(3D7) strain of P. falciparum. 
2. To evaluate the toxicity of the gall extracts on normal mouse fibroblast cell 
line (NIH/3T3), normal African green monkey kidney epithelial cell line 
(Vero), normal human umbilical vein endothelial cell (HUVEC), brine 
shrimps and human erythrocytes (A+, B+, AB+ and O+ blood groups). 
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3. To determine the content of heavy metals of lead (Pb), zinc (Zn), 
chromium (Cr), copper (Cu) and cadmium (Cd) in the gall extracts. 
4. To screen the phytochemical constituents of the gall extracts. 
5. To measure the pH of the digestive vacuole following treatment with the 
selected gall extract. 
 
1.4 Hypothesis of the study 
 
1. Q. infectoria gall crude extracts have promising antimalarial activity 
against the malaria parasite.  
2. Q. infectoria gall crude extracts have non-toxic effect on the normal cells, 
brine shrimps and normal erythrocytes and low concentration of heavy 
metals based on the permissible limit. 
3. Q. infectoria gall crude extracts are rich with phenolic compounds, which 
could be associated with antimalarial effect. 
4. Selected Q. infectoria gall crude extract alters the pH of the parasite’s 
digestive vacuole, leading to the parasite death. 
 
1.5 Experimental design 
 
The overall flow of the study, starting with the authentication of Q. 
infectoria galls at the Natural Medicinal Products Centre (NMPC), Universiti Islam 
Antarabangsa Malaysia (UIAM) was summarised in Figure 1.1. The galls were 
macerated using solvents with different polarity (acetone, methanol, ethanol and 
aqueous) to produce four different crude extracts.  
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The antimalarial activity of the gall crude extracts was determined using a 
malarial SYBR Green-I fluorescence-based (MSF) assay. Parasite cultures 
predominantly at the ring stage were synchronised with sorbitol before treatment with 
the gall extracts at different concentrations for 48 hours. The SYBR Green-I solution 
(2× final concentration from 10 000× stock concentration) was added to the parasite 
suspensions after 48 hours of treatment and the fluorescence signal was measured 
(excitation and emission wavelengths at 490 nm and 530 nm, respectively) and 
analysed to determine the concentration of the gall crude extracts that inhibits parasite 
population at half of maximum response (IC50). Giemsa-stained thin blood smears 
were also prepared at 24- and 48-hour post-treatment to observe the morphology of 
treated parasites. 
 
The cytotoxicity of the gall crude extracts was evaluated using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Normal mouse 
embryo fibroblast cell line (NIH/3T3), normal African green monkey kidney epithelial 
cell line (Vero) and normal human umbilical vein endothelial cell (HUVEC) were 
treated with the gall extracts at different concentrations for 72 hours before addition of 
MTT tetrazolium salt solution (0.4 mg/mL final concentration). The absorbance was 
measured at 570 nm and analysed to determine the concentration of the gall extracts 
that causes the reduction of cell viability by 50% (CC50). The selectivity index (SI) 
was calculated using a ratio of the CC50 to the IC50 obtained from the antimalarial 
assay. 
 
A brine shrimp lethality test (BSLT) was conducted as another cytotoxicity 
testing of the gall extracts. The gall extracts at different concentrations were tested for 
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their toxicity on mature brine shrimps for 24 hours. The percentage of mortalised 
shrimps was calculated to determine the lethality concentration that kills 50% of the 
shrimp population (LC50). 
 
The cytotoxicity of the gall crude extracts was further investigated on 
normal human erythrocytes using a haemolytic assay. Washed erythrocytes (2% 
haematocrit) from different blood groups (A+, B+, AB+ and O+) were treated with the 
gall extracts at different concentrations for 45 minutes. The absorbance of 
haemoglobin in the supernatants was measured at 450 nm and the results were 
recorded as the percentage of haemolysis (%). In addition to the haemolytic assay, the 
antioxidant assay was performed to determine whether the antioxidant activity of the 
gall extracts was associated with their haemolytic effect. The gall extracts at different 
concentrations were exposed with a free radical 2,2-diphenyl-1-picryl-hydrazyl-
hydrate (DPPH) solution and the absorbance was measured at 517 nm to determine the 
effective concentration requires to reduce 50% of free radical DPPH (EC50). 
 
The presence of heavy metals in the gall crude extracts was determined 
using atomic absorption spectroscopy (AAS). Lead (Pb), zinc (Zn), chromium (Cr), 
copper (Cu) and cadmium (Cd) were identified in the powdered form of the gall 
extracts and raw galls. The concentration of the heavy metals was compared with the 
permissible level commenced by WHO guidelines.  
 
Screening of different classes of phytochemicals such as phenolics, 
flavonoids, tannins, alkaloids and saponin in the gall crude extracts was carried out. 
The total phenolic content (TPC) and total flavonoid content (TFC) of the gall crude 
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extracts were also determined using Folin-Ciocalteu and aluminium chloride 
colourimetric methods, respectively. 
 
The effect of the crude extract, which exhibited a promising antimalarial 
activity and acceptable toxicity, on the digestive vacuole pH was investigated using a 
flow cytometry-based assay. The pH of the digestive vacuole was measured by the use 
of ratiometric pH indicator, the fluorescein isothiocyanate (FITC)-dextran 
incorporated into resealed erythrocytes via hypotonic dilution technique. A pH 
calibration curve was generated by incubating resealed erythrocytes in buffers at 
different pH in the presence of an ionophore, carbonyl cyanide-m-
chlorophenylhydrazone (CCCP) to equilibrate the pH of the erythrocyte compartments 
with the pH of the buffers. Ratios of the fluorescence intensity detected at two different 
wavelengths (530 and 585 nm) were plotted on a pH calibration curve.  
 
Synchronised mature stage parasites were harvested using MACS columns 
and inoculated with resealed erythrocytes preloaded with FITC-dextran to initiate 
infection. As the parasite matures, the probe along with haemoglobin was endocytosed 
and eventually accumulated in the digestive vacuole of the trophozoite stage parasites. 
Mid trophozoite stage parasites (~34-hour post-invasion) examined using Giemsa-
stained thin blood smears were adjusted to 5% parasitaemia (2% haematocrit) before 
treatment with the crude extract at different concentrations for 4 hours. The parasites 
were permeabilised with saponin (0.035% w/v) to release FITC-dextran in the host 
cell cytoplasm, allowing only FITC-dextran entrapped in the digestive vacuole to be 



























Figure 1.1: Flowchart of the experiments carried out through all the study  
Extraction of Q. infectoria galls 




Screening of the antimalarial activity of Q. 
infectoria gall extracts 
Determination of the toxicity of Q. 
infectoria gall extracts on: 
Assessment of the heavy metal contents 
(Pb, Zn, Cr, Cu, Cd) in Q. infectoria gall 
extracts 
Assessment of the phytochemical 
constituents of Q. infectoria gall extracts 
Determination of the digestive vacuole pH 
changes following treatment with selected 
Q. infectoria gall extract 
Synchronisation of ring-stage 
parasites 
Purification of mature stage 
parasites for invasion with 
FITC-dextran-containing 
resealed erythrocytes 
Authentication of Q. infectoria galls 
In vitro culture of P. 





















2.1 History of malaria  
 
Malaria is a parasitic disease that causes a serious burden in the world. It 
was initially described as a disease with high periodic fever originated from swampy 
air (Arifin et al., 2016; Barnett, 2016; Talapko et al., 2019). Others claimed that 
malaria was caused by a bacterium, Bacillus malariae until Charles Louis Alphonse 
Laveran (a French army physician) discovered the malaria parasite in the blood 
specimen in 1880 (Arifin et al., 2016). Six years later, the Italian physiologist, Camilo 
Golgi identified several Plasmodium species. In 1897, Ronald Ross (a surgeon) 
observed that malaria was transmitted via mosquitoes and later Giovanni Battista 
Grassi (an Italian professor) demonstrated that female Anopheles mosquitoes could 
transmit malaria to humans. From here, many studies to control and prevent the disease 
have emerged. 
 
2.2 Statistics of malaria 
 
In 2018, the World Health Organization (WHO) reported 228 million cases 
of malaria with global 405 000 deaths (WHO, 2019). The highest number of malaria 
cases and deaths was recorded in the African region, followed by the Southeast Asia, 
Eastern Mediterranean, Western Pacific and American regions (Figure 2.1). Malaysia 
is one of the countries who has achieved zero indigenous cases of human malaria in 
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2018, followed by China with a second consecutive year of zero indigenous cases. In 
Malaysia, although the malaria cases were reduced from 5194 to 514 cases in 2010 
and zero indigenous cases in 2018, the malaria-related deaths have still failed to reduce 
since 2010 (Figure 2.2). 
 
Four species of human malaria parasites are found in Malaysia, i.e. P. 
vivax, P, malariae, P. knowlesi and P. falciparum (Cowman et al., 2016; Davidson et 
al., 2019; Talapko et al., 2019). P. falciparum accounts for the most malaria cases and 
deaths, and poses a great risk of severe clinical presentations (Talapko et al., 2019; 
WHO, 2019). P. vivax, formerly recognised as one of the main causes of human 
malaria in Malaysia has now been replaced by zoonotic P. knowlesi, which naturally 
occurs in macaques (Lim et al., 2017; Davidson et al., 2019). The increasing cases of 
P. knowlesi malaria have been reported among aborigines practising forestry and 
peasant lifestyle in Malaysian Borneo and Peninsular Malaysia (Jeffree et al., 2018). 
Meanwhile, P. ovale rarely causes malaria in Malaysia, as it is widely distributed in 
Sub-Saharan Africa (Lim et al., 2017).  
 
2.3 Life cycle of the malaria parasite 
 
2.3.1 Sexual cycle of the malaria parasite 
 
Transmission of the malaria parasites from an infected human to a 
mosquito is mediated through sexual stage parasites called gametocytes (Figure 2.3) 
(Lim et al., 2017; Messina et al., 2018; Usui et al., 2019; Venugopal et al., 2020). A 




Figure 2.1: The prevalence of malaria projected by WHO in 2018 
Four WHO regions that are significantly affected by malaria are African, Southeast Asia, Eastern Mediterranean and Western Pa cific. European 
region remains to record zero indigenous malaria cases in 2018, while several countries in America and Western Pacific including Malaysia are 




Figure 2.2: Malaria cases and deaths in Malaysia from 2010 - 2018 
Malaysia reported decreasing cases of malaria from 5194 cases in 2010 to 242 cases in 2015 and zero indigenous cases in 2018. However,  the 
increasing number of deaths was reported from 2017-2018. Adapted from WHO (2019).
2010 2011 2012 2013 2014 2015 2016 2017 2018
Malaria cases 5194 3954 3662 2921 3147 242 266 85 0



























-metocytes undergo gametogenesis within the mosquito’s midgut, where the male 
microgametocyte divides into up to eight flagellated microgametes and the female 
macrogametocyte develops into a single macrogamete. The microgamete and 
macrogamete fuse to form a zygote. The zygote undergoes meiosis and develops into 
a motile ookinete. The ookinete migrates through the midgut epithelium and 
transforms into an oocyst (Figure 2.3A). The oocyst replicates to form thousands of 
sporozoites, which migrate and invade the mosquito’s salivary glands before infecting 
a new human host during a blood meal (Figure 2.3B). 
 
2.3.2 Asexual cycle of the malaria parasite 
 
Sporozoites are transmitted into a human during a blood meal of an 
infected mosquito (Figure 2.4A) (Cowman et al., 2016; Talapko et al., 2019; 
Venugopal et al., 2020). The sporozoites are taken into the liver to initiate the 
exoerythrocytic stage of infection (Figure 2.4B). The parasite invades the hepatocyte 
and subsequently produces many daughter hepatic merozoites (Figure 2.4C). The 
merozoites penetrate erythrocytes to start the intraerythrocytic stage of infection 
(Figure 2.4D). P. falciparum develops into distinct morphological stages around 48 
hours from a young ring to a mature trophozoite and a multinucleated schizont before 
releasing daughter merozoites.  
 
The ring stage parasites have a delicate cytoplasm with one or two 
chromatin dots observed in Giemsa-stained blood smears (Figure 2.5A) (Voulgaridi et 
al., 2016; Mahon & Lehman, 2019). Multiple infections are commonly seen and 
occasional appliqué forms (a parasite appearing on the erythrocyte periphery) can be
16 
 




Figure 2.3: The sexual reproduction of the malaria parasite within a 
mosquito vector 
Upon ingestion by a mosquito, the male gamete fuses with the female gamete to form 
a motile zygote. (A) The zygote undergoes several developmental transformations into 
an ookinete and then into an oocyst that matures beneath the basal lamina of the 
midgut’s epithelium. (B) The oocyst gives rise to infective sporozoites, which travel 
to the mosquito’s salivary glands, where they are transmitted to a new human host. 
Adapted from Sreenivasamurthy et al. (2013).
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present. A dense cytoplasm of the parasite and yellow malarial pigment (haemozoin) 
are clearly observed in the trophozoite stage (Figure 2.5B). At this stage, haemoglobin 
is actively metabolised to support the parasite growth and development before 
progression into the multinucleated schizont (see section 2.4 for details). The schizont 
bursts releasing 16-32 merozoites to initiate a new cycle of infection (Figure 2.5C). 
Patients will develop fever, rigours and other severe pathophysiologic conditions due 
to the stimulation of macrophages and other cells to produce cytokines and other 
soluble factors by haemozoin and other toxic factors (Cowman et al., 2016; Yusuf et 
al., 2017).  
 
2.4 Haemoglobin metabolism in the malaria parasite  
 
P. falciparum grows within the host erythrocyte and metabolises up to 
80% of the host cell haemoglobin as a source of nutrients and energy (Ginsburg, 2016; 
Lee et al., 2018). The haemoglobin metabolism involves the breakdown of 
haemoglobin into haem and globin and the build-up of crystalline non-toxic 
haemozoin; all of which occur during the intraerythrocytic cycle of the parasite 
(Ginsburg, 2016; Goldberg & Sigala, 2017). Specifically, this intricate metabolism is 
regulated by coordinated pathways right from haemoglobin ingestion, to haemoglobin 
transport, haemoglobin digestion and haem or haematin detoxification.  
 
2.4.1 Haemoglobin ingestion by the malaria parasite 
 
Several mechanisms have been suggested for the internalisation of 






Figure 2.4: The asexual reproduction of the malaria parasite within a 
human host 
(A) A female Anopheles mosquito transmits sporozoites into a human. (B-C) The 
sporozoites enter the liver and jeopardise the hepatocytes before releasing hepatic 
merozoites. (D) The merozoites infect the erythrocytes and progress into ring, 
trophozoite and schizont stages. Merozoites released after the schizont rupture infect 
other erythrocytes to repeat the intraerythrocytic cycle. (E) Some merozoites develop 
into gametocytes, which are taken up by a mosquito to continue the sexual 








Figure 2.5: Intraerythrocytic stages of P. falciparum 
During the intraerythrocytic cycle, the parasite diff erentiates into (A) a ring (B), a 




Bakar et al., 2010; Milani et al., 2015). Cytostome-dependent endocytosis is a major 
mechanism for the uptake of haemoglobin that commences early in the parasite’s 
intraerythrocytic development. It is also the principal pathway in the mature 
trophozoite stage (Figure 2.6A) (Milani et al., 2015; Wunderlich et al., 2012). 
Cytostomes are double-membrane invaginations of  the parasitophorous vacuolar 
membrane and the parasite plasma membrane that are morphologically distinguished 
by the presence of electron-dense material at the interface of the parasitophorous 
vacuolar membrane and parasite plasma membrane neck when observed under the 
serial thin-section electron microscope (Wunderlich et al., 2012; Goldberg & 
Zimmerberg, 2020; Matz et al., 2020).  
 
2.4.2 Haemoglobin transport by the malaria parasite 
 
Pinching off at the neck of cytostomes leads to the formation of small 
vesicles containing haemoglobin that is surrounded by two membranes: the outer 
membrane derived from the parasite plasma membrane and the inner membrane 
derived from the parasitophorous vacuolar membrane (Figure 2.6B) (Milani et al., 
2015; Goldberg & Zimmerberg, 2020). The cytostome-derived haemoglobin-filled 
vesicles use an actin-myosin motor system to deliver haemoglobin to the acidic 
digestive vacuole for degradation by proteases. The outer membrane of the vesicles 
fuses with the plasma membrane of the digestive vacuole, resulting in the delivery of 
single-membrane haemoglobin-filled vesicles to the digestive vacuole (Figure 2.6C). 
The digestive vacuole is identifiable by light or electron microscopy due to the 
presence of inert haemozoin (Kapishnikov et al., 2017; Pisciotta et al., 2017).  
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2.4.3 Haemoglobin digestion by the malaria parasite 
 
Haemoglobin is degraded primarily in the digestive vacuole of the malaria 
parasite by the action of proteases known as aspartic proteases (plasmepsins), cysteine 
proteases (falcipains) and metalloproteases (falcilysins) (Figure 2.6D) (Siklos et al., 
2015; Ponsuwanna et al., 2016; Mishra et al., 2019). Initially, plasmepsins, i.e. PfPM1, 
PfPM2, PfHAP and PfPM4 and falcipains, i.e. PfFP-2, PfFP-2’ and PfFP-3, which 
function in an acidic pH of 4.0 and 5.5, respectively are responsible for cleaving 
haemoglobin into oligopeptides and further digested into smaller peptides by 
falcilysins (Bonilla et al., 2007; Moura et al., 2009; Xie et al., 2016). Inhibition of one 
of the proteases by leupeptin or E-64 (calpain inhibitor N-acetyl-leucinyl-leucinyl-
norleucinal) and disruption of the PfFP-2-encoded gene caused incomplete digestion 
of haemoglobin in the digestive vacuole (Wunderlich et al., 2012; Siklos et al., 2015). 
Inhibition of PfPM1 and PfPM2 appeared to affect only on ring stage parasites, 
indicating that each of the proteases is expressed at different stages of parasite 
development (Liu et al., 2015).  
 
2.4.4 The digestive vacuole of the malaria parasite 
 
Plasmepsins and falcipains work optimally in the pH range of 4.0-5.5, 
which are the physiological pH of the digestive vacuole (Abu-Bakar, 2015; Liu et al., 
2015; Ibrahim & Abu-Bakar, 2019). The pH regulation of digestive vacuole has been 
demonstrated to rely on the action of proton pumps, i.e. vacuolar-type proton pump 




Figure 2.6: The schematic representation of the haemoglobin ingestion, transport and digestion by P. falciparum 
(A) The malaria parasite engulfs the host erythrocyte cytoplasm by means of a cytostomal system that arises from the PVM a nd PPM interface. 
(B-C) The cytostome buds and forms a small vesicle before being transported to and fused with the digestive vacuole in which hae moglobin is 
digested. (D) Haemoglobin is degraded by proteases (i.e. plasmepsins and falcipains), producing globin and haem, which is then detoxified into a 
malarial pigment, haemozoin. Abbreviations: PVM, parasitophorous vacoular membrane; PPM, parasite plasma membrane; Hb, haemoglobin. 
Modified from Wunderlich et al. (2012) and Milani et al. (2015).
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(V-type H+-PPase) that are located at the vacuole’s membrane (Figure 2.7) (Collins & 
Forgac, 2018; Dennis et al., 2018; Segami et al., 2018). The inhibition of V-type H+-
ATPase using the specific V-type H+-ATPase inhibitors, i.e. concanamycin A, 
bafilomycin A1 and N-ethylmaleimide resulted in the alkalinisation of the digestive 
vacuole and the acidification of the parasite cytosol, leading to parasite death (Forgac, 
2018; Tang et al., 2019). The activity of V-type H+-PPase was inhibited by the 
pyrophosphate analogues, i.e. aminomethylenediphosphonate, imidodiphosphate and 
sodium fluoride (Asaoka et al., 2016; Segami et al., 2018). Therefore, the digestive 
vacuole is essential for parasite growth and survival, and might represent a vulnerable 
target for future antimalarial drugs. 
 
2.4.5 Measurement of the pH of the digestive vacuole 
 
The pH of the malaria parasite’s digestive vacuole has been extensively 
studied to understand the haemoglobin digestion and haem detoxification (Spiller et 
al., 2002; Klonis et al., 2007; Moura et al., 2009), the mechanism of action of 
antimalarial drugs (Tang et al., 2019; Ibrahim et al., 2020) and the development of the 
malaria parasite resistance to antimalarial drugs (Homewood et al., 1972; Kirk & 
Saliba, 2001; Saliba et al., 2003). Given the diverse studies on the important roles of 
the digestive vacuole pH, methods on using pH-sensitive ratiometric fluorophores 
have been widely utilised for the quantification of digestive vacuole pH (Grillo-Hill et 




Figure 2.7: The schematic diagram of the proton pumps at the digestive vacuole’s membrane  
The pH regulation of the digestive vacuole is maintained by two types of proton pumps; A) V-type H+-ATPase and B) V-type H+-PPase. The V-
type H+-ATPase uses the energy from the hydrolysis of ATP, while the V-type H+-PPase utilises the energy from the hydrolysis of PPi to transport 
H+. ATP: adenosine triphosphate, PPi: pyrophosphate. Modified from Tresguerres (2016) and Baykov et al. (2013).
